Science News

Evidence-based Drug Therapy In Acute Heart Attacks

ScienceDaily (Oct. 27, 2008) — Patients who received treatment from noncardiologists and physicians with 29 or more years of experience had significantly lower use of evidence-based drug therapies compared with cardiologists and physicians with fewer than 14 years of experience, found a retrospective, population-based cohort study of heart attack patients.

The study, led by Dr. Peter Austin from the Institute for Clinical Evaluative Sciences Evaluative Sciences (ICES), looked at patients aged 65 and older in Ontario, Canada who had been discharged from hospital with a diagnosis of heart attack. The authors recommend developing new methods to improve prescribing practices and to target long-practicing physicians to standardize approaches.

In a related research study, Dr. Austin and coauthors report that prescriptions for statins, beta-blockers and others are currently filled after discharge by nearly 80% of elderly heart attack patients. Use of these drugs has increased since 1992 but the rate of increase in their use varied across physician and hospital characteristics.


Adapted from materials provided by Canadian Medical Association Journal.
Email or share this story:  
APA

MLA

Search ScienceDaily

Number of stories in archives: 44,032

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily's archives for related news topics,
the latest news stories, reference articles, science videos, images, and books.
 

Science Video News


Helping Cancer Survivors Grow Up

Studying childhood cancer patients who have suffered tissue and organ damage from chemotherapy treatments, researchers have found that growth. ...  > full story

Breaking News

... from NewsDaily.com

In Other News ...

Copyright Reuters 2008. See Restrictions.

Free Subscriptions

... from ScienceDaily

Get the latest science news with our free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Feedback

... we want to hear from you!

Tell us what you think of the new ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Post this page to your favorite social bookmarking site:
close
Include this item in your blog or web site:
close
Cite this article in your essay, paper, or report:
close
Email this page's link to a friend or colleague:
close